Sanders Morris Harris’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $217K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $272K | Hold |
|
|||||
|
2024
Q4 | $263K | Hold |
|
|||||
|
2024
Q3 | $281K | Hold |
|
|||||
|
2024
Q2 | $329K | Hold |
|
|||||
|
2024
Q1 | $349K | Hold |
|
|||||
|
2023
Q4 | $396K | Hold |
|
|||||
|
2023
Q3 | $346K | Hold |
|
|||||
|
2023
Q2 | $344K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $414K | Hold |
|
|||||
|
2022
Q3 | $347K | Hold |
|
|||||
|
2022
Q2 | $340K | Hold |
|
|||||
|
2022
Q1 | $308K | Hold |
|
|||||
|
2021
Q4 | $354K | Hold |
|
|||||
|
2021
Q3 | $311K | Hold |
|
|||||
|
2021
Q2 | $338K | Hold |
|
|||||
|
2021
Q1 | $312K | Hold |
|
|||||
|
2020
Q4 | $328K | Hold |
|
|||||
|
2020
Q3 | $320K | Buy |
|
|||||
|
2020
Q2 | $472K | Buy |
|